M. Iwakawa et al., INHIBITION OF BONE-MARROW METASTASIS BY CALMODULIN ANTAGONISTS IN MICE WITH C-1300 NEUROBLASTOMA, International journal of pediatric hematology/oncology, 4(4), 1997, pp. 423
The antitumor effect of calmodulin (CaM) antagonists against neuroblas
toma (NB) was examined. A total of 10(5) cells of C-1300 NE were inocu
lated intravenously into 8-week-old female mice to produce liver and b
one marrow metastases. The effects of CaM antagonists, such as trifluo
perazine, tamoxifen, melittin, or chlorpromazine, were tested in the t
reatment of distant metastasis. Liver metastases, where CaM content wa
s low, were not affected by CaM antagonists. However, intraperitoneal
injection of CaM antagonists 14 days after tumor cell inoculation inhi
bited the bone marrow metastases, where CaM content was high. These fi
ndings raise the possibility that CaM antagonists may have clinical va
lue for the treatment of bone marrow metastases of NE.